Researchers in Prof. A.C. Matin's laboratory have developed a versatile exosome (extracellular vesicle, "EV") drug delivery platform that can selectively target therapeutic agents to tumors or other tissues that overexpress extracellular receptors.
Researchers at Stanford have developed a novel therapeutic approach for dilated cardiomyopathy (DCM). DCM is characterized by left ventricular enlargement and reduced systolic function.
Researchers in Dr. Holden Maecker's lab have developed platinum-labeled probes to expand the analytical capacity of mass cytometry instruments. Currently, analytical capacity is limited by the ability to label specific probes with appropriate metal ions.
Stanford researchers have developed a new class of materials that enable new strategies for the efficient delivery of messenger RNA (mRNA) into cells and animals. The delivery materials are easily prepared (2 steps), stable and readily tuned.
A team of Stanford scientists have developed a technique to rapidly convert adult somatic cells directly into functional neuronal cells without the intermediate step of generating iPS cells (induced pluripotent stem cells).
Stanford researchers have developed a gene therapy that combines a retinal ganglion cell (RGC)- specific promoter with CRISPR gene editing to provide effective neuroprotection in optic neuropathies.
Stanford researchers have designed a frequency-multiplexed neural probe architecture that enables massive scaling of electrophysiological recording from neurons.
Stanford researchers have developed various high ionic conductivity thin films (LiAlO2, LiAlF4) to stabilize lithium ion battery electrodes without sacrificing power density.
The N2N allele contains a loxP site and an HA epitope upstream of exon 4, and a Frt-flanked neomycin resistance cassette (neo), followed by a luciferase sequence, downstream of exon 5, of the nuclear factor, erythroid derived 2, like 2 (Nfe212) gene.
Stanford researchers have developed and validated a quality assurance (QA) phantom that will facilitate the translation of a frameless volumetric modulated arc therapy radiosurgery technique.
Stanford has patented a fully homomorphic encryption (FHE) method, computer program, and apparatus that grant the ability to outsource data processing without giving away access to the data.
Stanford researchers in Professor Rhiju Das's lab have devised a method called RNAMake to optimize nucleic acids, such as aptamers and messenger RNAs, and enhance their effectiveness for clinical settings.